SEC Form 4Coverage since May 22, 2026
$ETON insider trading
Over the last 12 months, Eton Pharmaceuticals insiders reported no purchases and 5 sales totaling $14.5M across SEC Form 4 filings.
- Bought · 12m
- — 0 events
- Sold · 12m
- $14.5M 5 events
- Events · 12m
- 5 Form 4 filings, grouped
- Insiders · 12m
- 4 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $ETON · 12Mvia TradingView
Top insiders · 12m
Opaleye Management Inc.—2× · $5.8M
Adams Jennifer McKie—1× · $1.6M
Krempa DavidChief Business Officer1× · $3.2M
BRYNJELSEN SEANPresident & CEO1× · $3.8M
All insider trades
5 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 14, 2026 | Opaleye Management Inc.10% | ▼ Sale | 28,315 | $37.54 | $1.1M | -41.4% | 2 tranches · indirect |
| Jul 7, 2026 | Opaleye Management Inc.10% | ▼ Sale | 126,685 | $37.64 | $4.8M | -70.4% | 5 tranches · indirect |
| Jun 17, 2026 | Adams Jennifer McKieD | ▼ Sale | 50,000 | $32.48 | $1.6M | -100% | — |
| May 28, 2026 | BRYNJELSEN SEANPresident & CEO · O·D | ▼ Sale | 120,000 | $31.88 | $3.8M | -12.6% | 2 tranches |
| May 27, 2026 | Krempa DavidChief Business Officer · O | ▼ Sale | 100,000 | $32.3 | $3.2M | -79.8% | 5 tranches |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $ETON feed.